Search
29/05/2025
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly
Martel-Duguech, L, Bascuñana, H, Cuartero, J, Webb, SM, Valassi, E. Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly. Pituitary. 2025; 28(3)DOI:10.1007/s11102-025-01539-8. PMID:40442526. IF:3.400(Q2/4D).
27/05/2025
Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes
Rossell, J, Julve, J. Novel Experimental Dietary Supplementations to Combat Metabolic Alterations in Diabetes. Nutrients. 2025; 17(11)DOI:10.3390/nu17111816. PMID:40507085. IF:5.000(Q1/2D).
26/05/2025
Educational interventions and contextual factors for optimising antibiotic prescription in paediatric uncomplicated acute respiratory tract infections in primary care: scoping review of reviews
Elizondo-Alzola, U, Rocha, C, Leache, L, León-García, M, Saiz, LC, Solà, I, Montesinos-Guevara, C, Meade, AG, Boldú, A, Bolibar, I, Niño-de-Guzmán, E, Alonso-Coello, P. Educational interventions and contextual factors for optimising antibiotic prescription in paediatric uncomplicated acute respiratory tract infections in primary care: scoping review of reviews. BMC Pediatrics. 2025; 25(1)DOI:10.1186/s12887-025-05688-4. PMID:40420306. IF:2.000(Q2/4D).
26/05/2025
Socioeconomic characteristics, health and wellbeing of nonbinary adolescents in a Southern European City
Artazcoz, L, Carrere, J, Pérez, K, Sánchez-Ledesma, E, Serral, G, López, MJ. Socioeconomic characteristics, health and wellbeing of nonbinary adolescents in a Southern European City. BMC PUBLIC HEALTH. 2025; 25(1)DOI:10.1186/s12889-025-23080-w. PMID:40420040. IF:3.600(Q1/2D).
24/05/2025
Regulatory asymmetry in Alzheimer's disease care
Fortea, J, Boban, M, Engelborghs, S, Frederiksen, KS, Hort, J, Kennelly, S, Kramberger, MG, Mehrabian, S, Plantone, D, Paquet, C, Santana, I, Scarmeas, N, Solje, E, Spiru, L, Sutovsky, S, Vijverberg, EGB, Winblad, B, Jessen, F. Regulatory asymmetry in Alzheimer's disease care. LANCET. 2025; 405(10492)DOI:10.1016/S0140-6736(25)00907-9. PMID:40381642. IF:88.500(Q1/1D).
23/05/2025
Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study
Magallares, B, Cerdá, D, Betancourt, J, Fraga, G, Park, H, Codes-Méndez, H, Quesada-Masachs, E, López-Corbeto, M, Torrent, M, Marín, A, Herrera, S, Gich, I, Boronat, S, Casademont, J, Corominas, H, Malouf, J. Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1587985. PMID:40487764. IF:4.600(Q1/3D).
21/05/2025
URINARY PROTEOMIC ANALYSIS PROVIDES DIFFERENT PATTERNS BETWEEN LUPUS PATIENTS WITH AND WITHOUT NEPHRITIS: RESULTS OF A MULTICENTER STUDY IN 124 PATIENTS
Lucea, ER, García, NAR, Inchaurbe, A, Alén, JC, Aurrecoechea, E, Sola, AD, Zarrabeitia, LR, Diaz, M, Galindez, E, Fernández, O, Torre, I, Exposito, R, Allande, MJ, Abad-Plou, E, Alvarez, LV, Enjuanes, M, Gonzalez, G, Gonzalez, M, López, L, Barahona, E, Martínez, D, Alvarez, J, García-Vivar, ML. URINARY PROTEOMIC ANALYSIS PROVIDES DIFFERENT PATTERNS BETWEEN LUPUS PATIENTS WITH AND WITHOUT NEPHRITIS: RESULTS OF A MULTICENTER STUDY IN 124 PATIENTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).
21/05/2025
Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis
Mesa, A, Franch-Nadal, J, Navas, E, Mauricio, D. Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02791-9. PMID:40399939. IF:10.600(Q1/1D).
21/05/2025
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS
Vidal-Montal, P, Fabregat, A, Heredia, S, Bernardez, J, Magallares, BP, Gómez-Puerta, J, Frade-Sosa, B, Nolla, JM, Narváez, J. TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).
20/05/2025
In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant Escherichia coli
Cuyàs, B, Cantó, E, Sanchez-Ardid, E, Miró, E, Alvarado-Tapias, E, Román, E, Poca, M, Navarro, F, Ferrero-Gregori, A, Escorsell, MA, Vidal, S, Soriano, G. In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant Escherichia coli. Microorganisms. 2025; 13(5)DOI:10.3390/microorganisms13051164. PMID:40431335. IF:4.200(Q2/3D).
15/05/2025
25-year follow-up on marked ventricular repolarization abnormalities in athletes: Long-term outcomes and cardiovascular prognosis
Salido, M, Moliner-Abós, C, Zoratti, L, Puig, T, Carreras-Costa, F, Serra-Grima, R. 25-year follow-up on marked ventricular repolarization abnormalities in athletes: Long-term outcomes and cardiovascular prognosis. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 427DOI:10.1016/j.ijcard.2025.133060. PMID:40010514. IF:3.200(Q2/3D).
15/05/2025
Frameworks to support evidence-informed decision-making in public health and infectious disease prevention and control: a scoping review
Song, Y, Bracchiglione, J, Meneses-Echávez, J, Gomes, HD, Albiger, B, Solà, I, Rigau, D, Alonso-Coello, P. Frameworks to support evidence-informed decision-making in public health and infectious disease prevention and control: a scoping review. Eurosurveillance. 2025; 30(19)DOI:10.2807/1560-7917.ES.2025.30.19.2400185. PMID:40376818. IF:7.800(Q1/1D).
15/05/2025
Users' experience of frameworks to support evidence-informed decision-making in public health: a scoping review
Bracchiglione, J, Song, Y, Meneses-Echávez, JF, Gomes, HD, Albiger, B, Solà, I, Rigau, D, Alonso-Coello, P. Users' experience of frameworks to support evidence-informed decision-making in public health: a scoping review. Eurosurveillance. 2025; 30(19)DOI:10.2807/1560-7917.ES.2025.30.19.2400184. PMID:40376821. IF:7.800(Q1/1D).
15/05/2025
One-Year Recurrent Tricuspid Regurgitation After Successful Transcatheter Edge to Edge Repair: The TRI-SPA Registry
Echarte-Morales, J, Cepas-Guillén, P, Arzamendi, D, Moñivas, V, Carrasco-Chinchilla, F, Pan, M, Nombela-Franco, L, Pascual, I, Benito-González, T, Pérez, R, Gómez-Blázquez, I, Amat-Santos, IJ, Cruz-González, I, Sánchez-Recalde, A, Caneiro-Queija, B, Alvarez, ABC, Barreiro-Pérez, M, Sanchis, L, Li, CH, del Trigo, M, Martínez-carmona, JD, Mesa, D, Jiménez, P, Avanzas, P, Freixa, X, Estévez-Loureiro, R. One-Year Recurrent Tricuspid Regurgitation After Successful Transcatheter Edge to Edge Repair: The TRI-SPA Registry. AMERICAN JOURNAL OF CARDIOLOGY. 2025; 243DOI:10.1016/j.amjcard.2025.02.010. PMID:39984153. IF:2.100(Q3/6D).
15/05/2025
A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data
Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Génova, A, Reixach, E, Andrés, E, Pizarro, I, Mauricio, D, Perera-Lluna, A. A deep attention-based encoder for the prediction of type 2 diabetes longitudinal outcomes from routinely collected health care data. EXPERT SYSTEMS WITH APPLICATIONS. 2025; 274DOI:10.1016/j.eswa.2025.126876. PMID:. IF:7.500(Q1/1D).
14/05/2025
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations
Jimenez-Vicente, C, Cardus, A, Castaño-Diez, S, Ramil, G, Garcia-Avila, S, Gomez-Perez, L, Esteban, D, Arribas, I, Sturla, AL, Lopez-Guerra, M, Martinez-Roca, A, Cortes-Bullich, A, Perez-Valencia, AI, Zugasti, I, Monge, I, Carcelero, E, Vall-Llovera, F, Vives, S, Sierra, J, Nomdedeu, J, Oñate, G, Garrido, A, Pratcorona, M, Pomares, H, Arnan, M, Guijarro, F, Diaz-Beya, M, Esteve, J. Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations. Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-025-01298-6. PMID:40368916. IF:11.600(Q1/1D).
14/05/2025
Early mobilization after skin graft for burn injury in adults.
Sousa, Tamara S, Jardim, Roger Andrey Carvalho, Silva, Caroline Fr, Sousa, Andre S, Iosimuta, Natalia, Trevisani, Virginia Fm, Pinto, Ana Carolina Pereira Nunes. Early mobilization after skin graft for burn injury in adults.. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2025; 5DOI:10.1002/14651858.CD016109. PMID:. IF:(Q/D).
13/05/2025
Influence of Asymptomatic Hemorrhagic Transformation After Endovascular Treatment on Stroke Outcome
Guasch-Jiménez, M, Díaz, GE, Lambea-Gil, A, Ramos-Pachón, A, Martinez-Domeño, A, Prats-Sanchez, L, Fernández-Vidal, JM, Toscano-Prat, C, Marti-Fabregas, J, Martínez-González, JP, Fernandez-Cadenas, I, Cardona, P, Rodriguez-Villatoro, N, Vázquez, AR, Gomis, M, Xuclà-Ferrarons, T, Rodriguez-Campello, A, Cánovas, D, Seró, L, Purroy, F, Salvat-Plana, M, Abilleira, S, Camps-Renom, P. Influence of Asymptomatic Hemorrhagic Transformation After Endovascular Treatment on Stroke Outcome. NEUROLOGY. 2025; 104(9)DOI:10.1212/WNL.0000000000213509. PMID:40228188. IF:8.500(Q1/1D).
13/05/2025
Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases
Ortiz, MA, Anguera, G, Cantó, E, Alejandre, J, Mora, J, Osuna-Gómez, R, Mulet, M, Mora, P, Antonijuan, A, Sánchez, S, Ramírez, O, Orantes, V, Maroto, P, Vidal, S. Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(10)DOI:10.3390/ijms26104669. PMID:40429810. IF:4.900(Q1/3D).
12/05/2025
SILITOX Study: international multicenter study on the effectiveness of EXTRIP recommendations in preventing the development of syndrome of irreversible lithium neurotoxicity (SILENT) and mortality
Caballero-Bermejo, AF, Pineda-Torcuato, A, Córdoba, F, Climent, B, Lobo-Antuña, V, Gallardo-Sánchez, BA, Sánz-López, N, Samper, VM, Mora, S, Laoi, RO, Supervía, A, Callado, F, del Aguila, MLM, Urroz, M, Canseco, X, Jiménez, MDG, Cózar-Llistó, A, Perez, BM, García, SV, Sanmillán, IL, Salgado, E, Gonzalo, JL, Gutiérrez, E, Capilla, R, Puiguriguer, J, Ruiz-Antorán, B. SILITOX Study: international multicenter study on the effectiveness of EXTRIP recommendations in preventing the development of syndrome of irreversible lithium neurotoxicity (SILENT) and mortality. CLINICAL TOXICOLOGY. 2025; 63DOI:. PMID:. IF:3.300(Q2/4D).